Manasi Kapoor, Oncology Roundtable
With the move toward value-driven payment models, financial performance will be tied to care quality and patient outcomes. Research has shown that engaged patients are more likely to adhere to treatment guidelines and have better health outcomes, and oncology is no different. The proliferation of oral chemotherapeutics has elevated the need for active patient engagement to ensure compliance and appropriate management of side effects.
While engaging patients has always been a top priority, risk-based payment models mean that there are also have the financial incentives to support these goals. It's nice to be paid for something providers already care about, but creating a structured, robust system to support that goal is challenging.
Crafting care plans with patients in mind
Deirdre Fuller, Oncology Roundtable
New American Society of Clinical Oncology (ASCO) resources aim to help oncology providers address tobacco use by cancer patients and subsequently improve patient outcomes.
Tobacco use complicates treatment
Tobacco use is known to negatively impact overall quality of life. Additionally, a growing amount of evidence suggests that tobacco use can complicate several of cancer treatments, including:
- Radiation therapy
ASCO resources help cancer providers address tobacco use
Megan Bailey, Oncology Roundtable
Six new hospitals have joined the Commission on Cancer’s ProvenCare Lung Cancer Collaborative, doubling the number of sites participating in the pilot study.
Started in 2010, the Lung Cancer Collaborative uses Geisinger Health Care's ProvenCare model to provide evidence-based treatment for patients with non-small cell lung cancer (NSCLC) who are candidates for lung resections. Participating hospitals provide treatment according to a care pathway containing 38 standardized elements provided by interdisciplinary teams from the preoperative to postoperative period.
ProvenCare Lung Cancer Collaborative expands to six new sites